Skip to main content
. 2002 Nov 18;99(24):15584–15589. doi: 10.1073/pnas.242608099

Table 1.

Clinical data of subjects used in our study

Subjects
Sample intervals, years
Sample number
Age, years
Age at infection, years
Risk factors
Gender
Race
HBc Ab
Degree of chronic hepatitis, HAI
Mild Moderate Bridging Cirrhosis
CF 15.6 4 71 48 BTF (1977) M B Neg X
FM 20.6 5 55 32 BTF (1978) M W Neg X
JL 21.6 4 52 24 BTF (1973) F B Neg X
HW 17.7 7 84 60 BTF (1977) M W Neg X
PR 15.5 4 62 39 BTF (1978) M W Neg X
PEN 17.8 4 53 29 BTF (1977) M W Neg X
KM 19 2 76 46 BTF (1971) M W Neg X
C107 8 2 41 <21 IDU (1972) F W Neg X
C115 8.1 2 44 <24 Unknown M W Neg X
C159 7 2 49 29–33 OPE (1989) F B Neg X

The first seven subjects were enrolled in prospective studies of transfusion-associated hepatitis conducted at the National Institutes of Health starting in 1972 (15) and the final three subjects were from anti-HCV positive blood donors whose exposure history suggested infection of >20 years' duration (16).

*

BTF, blood transfusion; IDU, injection drug user; OPE, surgical operation. The putative infection time appears in parentheses.

B, African American; W, Caucasian; HBcAb, antibody to HBV core antigen; Neg, negative.